technetium tc 99m pentetate has been researched along with Hepatic Encephalopathy in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Abe, H; Kakisaka, K; Mikami, R; Sasaki, T; Sato, T; Suzuki, Y; Takikawa, Y | 1 |
Enomoto, M; Ikeoka, N; Kobayashi, K; Kuroki, T; Masaki, K; Ochi, H; Shiomi, S; Takeda, T; Ueda, T | 1 |
Kuriyama, M; Kuroki, T; Nakajima, S; Nishiguchi, S; Ochi, H; Shiomi, S; Takeda, T; Tanaka, T | 1 |
Habu, D; Iwata, Y; Kuroki, T; Kurooka, H; Nishiguchi, S; Ochi, H; Sasaki, N; Shiomi, S; Takeda, T; Tamori, A | 1 |
Camp, VM; Faraj, BA; Malveaux, E; Sarper, R; Schmidt, FH | 1 |
5 other study(ies) available for technetium tc 99m pentetate and Hepatic Encephalopathy
Article | Year |
---|---|
Tc-99m GSA scintigraphy within the first 3 days after admission as an early predictor of outcome in severe acute liver injury.
Topics: Adult; Aged; Hepatectomy; Hepatic Encephalopathy; Humans; Liver; Liver Failure, Acute; Liver Function Tests; Liver Transplantation; Male; Middle Aged; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Aggregated Albumin; Technetium Tc 99m Pentetate | 2021 |
Fulminant hepatic failure monitored by technetium-99m-DTPA-galactosyl-human serum albumin scintigraphy.
Topics: Adult; Asialoglycoprotein Receptor; Atrophy; Carrier Proteins; Female; Follow-Up Studies; Galactose; Heart; Hepatic Encephalopathy; Humans; Liver; Radionuclide Imaging; Technetium Tc 99m Aggregated Albumin; Technetium Tc 99m Pentetate; Time Factors | 1996 |
Evaluation of fulminant hepatic failure by scintigraphy with technetium-99m-GSA.
Topics: Acute Disease; Adolescent; Adult; Aged; Chronic Disease; Female; Hepatic Encephalopathy; Hepatitis; Humans; Liver; Male; Middle Aged; Prognosis; Radionuclide Imaging; Technetium Tc 99m Aggregated Albumin; Technetium Tc 99m Pentetate | 1997 |
Clinical need for both scintigraphy with technetium-99m GSA and per-rectal portal scintigraphy in some patients with chronic liver disease.
Topics: Administration, Rectal; Ascites; Esophageal and Gastric Varices; Hepatic Encephalopathy; Hepatitis; Humans; Liver; Liver Cirrhosis; Metabolic Clearance Rate; Portal System; Radionuclide Imaging; Radiopharmaceuticals; Reference Values; Regression Analysis; Technetium Tc 99m Aggregated Albumin; Technetium Tc 99m Pentetate; Tissue Distribution | 1999 |
Tyramine neurotoxicity and first-pass brain technetium-99m-diethylenetriamine penta-acetic acid.
Topics: Animals; Brain; Cerebrovascular Circulation; Chemical and Drug Induced Liver Injury; Dogs; Dopamine; Drug Interactions; Epinephrine; Hepatic Encephalopathy; Intracranial Pressure; Kinetics; Mathematics; Monoamine Oxidase Inhibitors; Norepinephrine; Organometallic Compounds; Pentetic Acid; Phenelzine; Radionuclide Imaging; Technetium; Technetium Tc 99m Pentetate; Tyramine | 1987 |